Application of MR mammography beyond local staging: Is there a potential to accurately assess axillary lymph nodes? Evaluation of an extended protocol in an initial prospective study

American Journal of Roentgenology

Volumn 196, Issue 5, 2011, Pages

  Baltzer, Pascal A T ^a   Dietzel, Matthias ^a   Burmeister, Hartmut P ^a   Zoubi, Ramy ^a   Gajda, Mieczyslaw ^a   Camara, Oumar ^a   Kaiser, Werner A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Breast neoplasms; Lymph nodes; Metastasis; MRI; Neoplasm; Pathology; Sensitivity; Specificity

Indexed keywords

GADODIAMIDE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EDEMA; FEMALE; HISTOPATHOLOGY; HUMAN; INTERRATER RELIABILITY; LYMPH NODE METASTASIS; MAGNETIC RESONANCE MAMMOGRAPHY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; AXILLA; BREAST TUMOR; CARCINOMA; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; LYMPH NODE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA; CLINICAL PROTOCOLS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 79959622761     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4889     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249
2. Edge S, Byrd D, Carducci M, Wittekind C, eds. TNM classification of malignant tumours, 7th ed. New York, NY: Springer-Verlag, 2009
3. Michaelson JS, Silverstein M, Sgroi D, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 2003; 98: 2133-2143 (Pubitemid 37392416)
4. 18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 2008; 26:4746-4751
5. Kilbride KE, Lee MC, Nees AV, et al. Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence. Ann Surg Oncol 2008; 15:3252-3258
6. Abe H, Schmidt RA, Kulkarni K, Sennett CA, Mueller JS, Newstead GM. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy - clinical experience in 100 patients. Radiology 2009; 250:41-49
7. DeMartini W, Lehman C. A review of current evidence-based clinical applications for breast magnetic resonance imaging. Top Magn Reson Imaging 2008; 19:143-150
8. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26:3248-3258
9. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006; 238:42-53 (Pubitemid 43010579)
10. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356:1295-1303 (Pubitemid 46513295)
11. Sardanelli F. Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast 2010; 19:3-6
12. Sardanelli F, Hunink MG, Gilbert FJ, Di Leo G, Krestin GP. Evidence-based radiology: why and how? Eur Radiol 2010; 20:1-15
13. Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2000; 10:1464-1471
14. Mortellaro VE, Marshall J, Singer L, et al. Magnetic resonance imaging for axillary staging in patients with breast cancer. J Magn Reson Imaging 2009; 30:309-312
15. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR 1997; 169:417-424 (Pubitemid 27334851)
16. Murray AD, Staff RT, Redpath TW, et al. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 2002; 75:220-228 (Pubitemid 34436274)
17. Luciani A, Dao TH, Lapeyre M, et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. AJR 2004; 182:1059-1067 (Pubitemid 38391675)
18. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology 2003; 226:24-28 (Pubitemid 36163903)
19. Sardanelli F, Di Leo G. Biostatistics for radiologists. New York, NY: Springer-Verlag, 2009
20. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 2008; 18:1307-1318
21. Obuchowski NA, Mazzone PJ, Dachman AH. Bias, underestimation of risk, and loss of statistical power in patient-level analyses of lesion detection. Eur Radiol 2010; 20:584-594
22. American College of Radiology. Breast imaging reporting and data system (BI-RADS), 4th ed. Reston, VA: American College of Radiology, 2003
23. Esen G. Ultrasound of superficial lymph nodes. Eur J Radiol 2006; 58:345-359 (Pubitemid 43729061)
24. Baltzer PA, Yang F, Dietzel M, et al. Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions. Breast J 2010; 16: 233-239
25. Solbiati L, Cioffi V, Ballarati E. Ultrasonography of the neck. Radiol Clin North Am 1992; 30:941-954
26. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. Part 1. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19:403-410
27. Schmidt GP, Baur-Melnyk A, Haug A, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 2008; 65:47-58
28. Pugliese MS, Stempel MM, Cody HS 3rd, Morrow M, Gemignani ML. Surgical management of the axilla: do intramammary nodes matter? Am J Surg 2009; 198:532-537
29. Kinoshita T, Odagiri K, Andoh K, et al. Evaluation of small internal mammary lymph node metastases in breast cancer by MRI. Radiat Med 1999; 17:189-193 (Pubitemid 29330350)
30. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004; 70:225-230 (Pubitemid 38520153)
31. de Kanter AY, Menke-Pluijmers MB, Henzen-Logmans SC, et al. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement. Eur J Surg Oncol 2006; 32:498-501